Therapeutical Class：Carbapenems, inhibit cell wall synthesis by inhibiting the final transpeptidation step of peptidoglycan synthesis

Indication：G(+): not for MRSA or Enterococcus; G(-): not for Pseudomonas, Acinetobacter. Anaerobes.

Administraton：IV or IM.

Adults: 1 g qd.

Children: 15 mg/kg bid; max 1g/day.

Renal impairment: Ccr<30 ml/min, ESRD, 0.5 g qd.

Contraindication：Hypersensitivity to beta-lactams or lidocaine (IM injection).

Adverse Effect：Diarrhea (1-10%), phlebitis, constipation(1-10%), thrombophlebitis, allergy (rash,etc), nausea, headache (1-10%), vomiting.

Pregnancy Risk：B

Supply：Invanz XE “Invanz” Inj 1g（益滿治注射劑 MSD）＜10614＞